ProVerum Medical

ProVerum Medical is an early stage medical device company developing an innovative medical device technology to treat Benign Prostatic Hyperplasia (BPH). BPH is enlargement of the prostate gland which causes difficulty with urination.

Validated Problem

BPH is enlargement of the prostate gland which causes difficulty with urination.
Over 25% of men over 50 years of age will have symptoms of BPH

ProVerum’s Proposed Solution

ProVerum has developed a unique expander device to treat BPH. It is effective, has shorter procedural times and less side effects.

ProVerum’s Website

Website

ProVerum’s LinkedIn Page

Other Portfolio Companies

VertiGenius

VertiGenius are developing a new way to consult and manage patients with vertigo, imbalance, and dizziness.

X-Bolt Orthopedics

Focused on research, development, and commercialization of highly innovative fixation devices for treatment of hip fractures.

Bluedrop Medical

Bluedrop Medical is focused on developing a device which can predict the formation of diabetic foot ulcers.

CroiValve

CroíValve is an early-stage medical device company developing a minimally invasive device for treating tricuspid regurgitation.

Disclaimer

Ascentifi does not and will not provide any form of financial services or investment advice to any party. We do not promote, recommend, or sell investments. We bring start-up companies to the attention of investors. If an investor chooses to invest, we help facilitate the investment process.

The investment decisions an investor makes are the sole responsibility of the investor. Ascentifi does not assess the appropriateness of an investors investment experience and knowledge when bringing start-up companies to their attention.

Please read our full Disclaimer

Risk Warning

Investing involves risks, including total loss of capital, illiquidity, dilution, and lack of dividends. It is suitable only for investors capable of evaluating and bearing those risks.

Your investment is not covered by the deposit guarantee schemes established in accordance with Directive 2014/49/EU of the European Parliament and of the Council. Nor is your investment covered by the investor compensation schemes established in accordance with Directive 97/9/EC of the European Parliament and of the Council.

Please read our full Risk Warning

ProVerum Medical